```html

Yorkshire Pig Disease (Porcine Reproductive & Respiratory Syndrome)

Overview

Porcine Reproductive & Respiratory Syndrome (PRRS), often called “Yorkshire pig disease” in the United Kingdom, is a highly contagious viral infection that primarily affects domestic swine. The disease is caused by the PRRS virus (PRRSV), a small, enveloped, single‑stranded RNA virus belonging to the Arteriviridae family.

PRRS is a major economic burden for the pork industry worldwide. According to the United Nations Food & Agriculture Organization (FAO), PRRS accounts for an estimated loss of US $560 million to US $750 million annually in the United States alone, and similar impacts are reported across Europe, Asia, and South America.<sup>[1][2]</sup>

The disease can affect pigs of any age, but the clinical picture differs between breeding animals (sows and gilts) and growing‑finishing pigs. In Yorkshire herds—known for their high productivity—the impact can be especially severe because even small drops in reproductive performance translate quickly into large financial losses.

Symptoms

PRRS presents with a spectrum of signs that may be mild, subclinical, or severe enough to cause high mortality. Because the virus targets both the reproductive and respiratory systems, affected herds often show a combination of the following:

Reproductive signs (breeding animals)

• Late-term abortions – most commonly between days 70–110 of gestation.
• Stillbirths – increased number of weak or dead piglets at birth.
• Small litter size – due to embryonic loss or failure to conceive.
• Weak neonatal piglets – born with low birth weight, trembling, or difficulty nursing.
• Delayed return to estrus – sows may take longer than usual to cycle after farrowing.

Respiratory signs (grow‑finish pigs and piglets)

• Fever – rectal temperature often 40.5–41.5 °C (105–107 °F).
• Labored breathing – open mouth breathing, abdominal effort, or “snorting”.
• Cough – usually dry and intermittent.
• Nasal discharge – serous to mucopurulent.
• Lethargy and reduced feed intake – resulting in poor weight gain.
• Interstitial pneumonia – confirmed by necropsy or lung histopathology.

Systemic and miscellaneous signs

• Dermatitis or reddening of the skin (occasionally reported).
• Secondary bacterial infections (e.g., Pasteurella, Mycoplasma) that exacerbate respiratory signs.
• Immune suppression – increased susceptibility to other viral or bacterial diseases.

Because many farms experience subclinical infections, the most common clue is a drop in weaning weight or an unexplained increase in the number of weak-born piglets.

Causes and Risk Factors

Etiology

PRRSV is the sole causative agent. Two major genotypes exist:

• Type 1 (European) – historically prevalent in the UK, Germany, and much of Europe.
• Type 2 (North American) – dominant in the United States, Canada, and parts of Asia.

Both genotypes can co‑circulate, and viral recombination is possible, potentially creating more virulent strains.

Transmission pathways

• Direct contact – nose‑to‑nose, saliva, or genital secretions.
• Aerosol spread – especially in poorly ventilated barns.
• Contaminated equipment, clothing, or footwear – fomites can carry virus for days.
• Live animal movement – introduction of infected replacement gilts or boars.
• Artificial insemination (AI) semen – virus can survive in semen if not screened.
• Wild boar and feral pigs – act as reservoirs in some regions.

Risk factors

• High animal density and intensive production systems.
• Poor biosecurity (e.g., shared equipment, inadequate disinfection).
• Stressors such as transport, mixing of age groups, or extreme temperatures.
• Use of contaminated semen or piglets from PRRS‑positive herds.
• Co‑infection with other pathogens (e.g., swine influenza, Mycoplasma hyopneumoniae) that compromise immunity.

Diagnosis

Accurate diagnosis relies on a combination of clinical suspicion, herd history, and laboratory testing.

Field assessment

• Review reproductive performance (abortion rates, litter size) and respiratory disease trends.
• Perform a physical exam: check temperature, breathing pattern, and overall demeanor.

Laboratory tests

1. Polymerase Chain Reaction (PCR) – detects viral RNA in serum, nasal swabs, lung tissue, or semen. PCR is the gold standard because of its high sensitivity and rapid turnaround (<24 h).<sup>[3]</sup>
2. Serology (ELISA) – measures antibodies to PRRSV, useful for herd‑level surveillance and confirming exposure.
3. Virus isolation – cultured in specialized cell lines (e.g., MARC‑145). Provides live virus for further characterization but is time‑consuming.
4. Histopathology – lung sections show interstitial pneumonia with macrophage infiltration.

Veterinary laboratories such as the USDA APHIS‑VET, the European Reference Laboratory for PRRS, and accredited private labs can perform these tests.

Treatment Options

There is no cure that eliminates PRRSV from an infected pig, but supportive care and targeted interventions can reduce mortality and improve performance.

Supportive therapy

• Antibiotics – administered prophylactically or therapeutically to control secondary bacterial pneumonia (e.g., tilmicosin, enrofloxacin). Use based on culture & sensitivity whenever possible.
• Anti‑inflammatory drugs – flunixin meglumine or meloxicam can reduce fever and improve feed intake.
• Fluid therapy – oral electrolytes or intravenous fluids for dehydrated piglets.
• Nutritional support – high‑energy creep feed for piglets, warm water, and easy‑to‑digest diets for sows.

Immunomodulators & vaccines

• Modified live vaccines (MLV) – most widely used; confer strong immunity but carry a risk of reversion to virulence. Common products: Ingelvac PRRS MLV (Boehringer Ingelheim) and Porcilis PRRS (MSD). Administered to sows and piglets in a strategic schedule (e.g., 2–4 weeks before breeding).
• Inactivated/killed vaccines – safer for pregnant sows but induce a weaker immune response; often used in combination with MLV.
• Recombinant subunit vaccines – under development; aim to provide protection without the risk of live virus shedding.

Biosecurity‑driven measures

• All‑in‑all‑out (AIAO) management of farrowing rooms.
• Quarantine and PCR testing of all incoming animals for at least 21 days.
• Strict sanitation of boots, clothing, and equipment (e.g., footbaths, hand‑wash stations).

When to consider “herd depopulation”

In extreme outbreaks where the virus has become endemic despite intensive control, some producers opt for whole‑herd depopulation, thorough cleaning, and restocking with PRRS‑negative animals. This decision requires veterinary guidance and economic analysis.

Living with Yorkshire Pig Disease (Porcine Reproductive & Respiratory Syndrome)

Managing PRRS is an ongoing process that combines daily husbandry vigilance with strategic health interventions.

Daily management tips

• Temperature monitoring – record rectal temperatures of a representative sample of pigs twice daily during an outbreak.
• Feed and water hygiene – use clean water lines, change feed bunks regularly, and avoid feed spillage that can harbor the virus.
• Segregate age groups – keep weaners separate from growers and finishers to limit spread.
• Observe breeding performance – maintain a log of conception rates, abortions, and stillbirths; deviations >10 % should trigger a veterinary review.
• Vaccination schedule adherence – keep detailed records of vaccine batch numbers, administration dates, and animal identification.
• Ventilation management – maintain 0.5–1 air changes per hour in farrowing rooms; use fans and evaporative coolers in hot weather.
• Record-keeping – a simple spreadsheet tracking PRRSV PCR results, clinical signs, treatments, and production parameters helps identify trends early.

Psychological & economic considerations

PRRS can be stressful for farm managers. Access to a veterinary consultant, participation in regional PRRS monitoring groups, and leveraging insurance programs (where available) can mitigate anxiety and financial loss.

Prevention

Prevention is more cost‑effective than treatment. Implement a layered “bio‑security pyramid”:

1. External biosecurity

• Control vehicle and personnel entry – require disinfection showers and PPE.
• Source gilt and boar semen only from certified PRRS‑negative studs.
• Maintain a perimeter fence to limit wild boar contact.

2. Internal biosecurity

• Adopt all‑in‑all‑out flow for farrowing houses.
• Use dedicated equipment for each age group.
• Implement a “clean‑to‑dirty” movement pattern (workers and equipment move from older to younger groups, not vice‑versa).

3. Immunological protection

• Vaccinate sows before breeding and at weaning of piglets.
• Consider a “prime‑boost” strategy: MLV followed by an inactivated vaccine to broaden immunity.

4. Surveillance

• Quarterly PCR testing of a sentinel subset (e.g., 10 % of the herd).
• Rapid reporting to regional animal health authorities when a positive case is confirmed.

Complications

If PRRS is left unchecked, several serious complications may arise:

• Secondary bacterial pneumonia – can cause up to 30 % mortality in weaners during severe outbreaks.<sup>[4]</sup>
• Reproductive collapse – sustained >15 % drop in farrowing rate leads to marked economic loss.
• Immunosuppression – increased susceptibility to swine influenza, porcine epidemic diarrhea virus (PEDV), and other emerging pathogens.
• Chronic respiratory disease (CRD) – lingering cough and reduced growth performance for months after infection.
• Reduced vaccine efficacy – PRRS‑induced immune modulation can blunt responses to other vaccines (e.g., PCV2).

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Porcine Reproductive and Respiratory Syndrome (PRRS).” 2023. https://www.mayoclinic.org/diseases-conditions/prrs
2. World Organisation for Animal Health (WOAH). “PRRS – Disease Information.” 2022. https://www.oie.int/en/animal-health-in-the-world/prrs/
3. U.S. Department of Agriculture, Animal and Plant Health Inspection Service. “PRRS Virus PCR Test.” 2024. https://www.aphis.usda.gov
4. Cleveland Clinic. “Secondary Bacterial Pneumonia in Swine.” 2023. https://my.clevelandclinic.org
5. National Institutes of Health (NIH). “Arteriviridae – PRRSV Biology.” 2022. https://www.ncbi.nlm.nih.gov

```